Reslizumab
CAS: 241473-69-8
Ref. TM-T12706
| 1mg | 621.00 € | ||
| 5mg | 1,660.00 € | ||
| 10mg | 2,232.00 € | ||
| 25mg | 3,310.00 € | ||
| 50mg | 4,482.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
Reslizumab
Synonyms:
- Sch55700
- DCP-835
- DCP835
- CEP-38072
- CEP38072
- Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer
- Sch 55700
- DCP 835
- Cinquil
Description:
Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG) 4 κ monoclonal antibody, thereby reducing eosinophil production and survival.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
N/A
Purity:
98%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T12706 Reslizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
